Jacques Galipeau

Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature

Sowmya Viswanathan, Yufang Shi, Jacques Galipeau et al. · Cytotherapy · 2019 · 777 citations

Regenerative Medicine, Cell Therapy, Developmental Biology +12

Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation

Moïra François, Raphaëlle Romieu‐Mourez, Mengyang Li et al. · Molecular Therapy · 2011 · 700 citations · Full text

Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice

Nicoletta Eliopoulos, John Stagg, Laurence Lejeune et al. · Blood · 2005 · 552 citations

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Jacques Galipeau, Mauro Krampera, John Barrett et al. · Cytotherapy · 2015 · 491 citations · Full text

Cell Therapy, International Society, Medicine +10

Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal

Mauro Krampera, Jacques Galipeau, Yufang Shi et al. · Cytotherapy · 2013 · 458 citations · Full text

Regenerative Medicine, Cells—the International Society, Cell Therapy +13